MétaCan
Menu
Back to cohort
Record W4402766756 · doi:10.1016/j.eclinm.2024.102838

Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials – insights from an expert virtual roundtable

2024· review· en· W4402766756 on OpenAlexaff
Christina Yap, Olalekan Lee Aiyegbusi, Emily Alger, Ethan Basch, Jill A. Bell, Vishal Bhatnagar, David Cella, Philip Collis, Amylou C. Dueck, Alexandra Gilbert, Ari Gnanasakthy, Alastair Greystoke, Aaron R. Hansen, Paul Kamudoni, Olga Kholmanskikh, Bellinda L. King‐Kallimanis, Harlan M. Krumholz, Anna Minchom, Daniel O’Connor, Joan Petrie, Claire Piccinin, Khadija Rantell, Saaeha Rauz, Ameeta Retzer, Steven Rizk, Lynne I. Wagner, Maxime Sasseville, Lesley Seymour, Harald Weber, Roger Wilson, Melanie Calvert, John Devin Peipert

Bibliographic record

VenueEClinicalMedicine · 2024
Typereview
Languageen
FieldEconomics, Econometrics and Finance
TopicHealth Systems, Economic Evaluations, Quality of Life
Canadian institutionsHealth Canada
FundersJanssen PharmaceuticalsNational Institute for Health Research Applied Research Collaboration WestMSD K.K.GenentechChugai PharmaceuticalAgency for Healthcare Research and QualityCenters for Disease Control and PreventionNational Institutes of HealthShionogiAstellas PharmaEisaiCancer Research UKNational Eye InstituteSeagenNational Institute for Health and Care ResearchMedical Research CouncilVerily Life SciencesDepartment of Health and Social CareMacroGenicsImperial Experimental Cancer Medicine CentreAnthony NolanMassachusetts Medical SocietySarcoma UKNational Cancer InstituteGilead SciencesYale UniversityGlaxoSmithKlineUK Research and InnovationEli Lilly and CompanyBristol-Myers SquibbAstraZenecaAmgenBirmingham Biomedical Research CentrePfizerAstex PharmaceuticalsPfizer PharmaceuticalsAmerican Heart Association
KeywordsMedicineTolerabilityClinical trialPatient carePhase (matter)Medical physicsIntensive care medicineAlternative medicineNursingInternal medicinePathology

Abstract

fetched live from OpenAlex

Early phase clinical trials provide an initial evaluation of therapies' risks and benefits to patients, including safety and tolerability, which typically relies on reporting outcomes by investigator and laboratory assessments. Use of patient-reported outcomes (PROs) to inform risks (tolerability) and benefits (improvement in disease symptoms) is more common in later than early phase trials. We convened a two-day expert roundtable covering: (1) the necessity and feasibility of a universal PRO core conceptual model for early phase trials; (2) the practical integration of PROs in early phase trials to inform tolerability assessment, guide dose decisions, or as real-time safety alerts to enhance investigator-reported adverse events. Participants (n = 22) included: patient advocates, regulators, clinicians, statisticians, pharmaceutical representatives, and PRO methodologists working across diverse clinical areas. In this manuscript, we report major recommendations resulting from the roundtable discussions corresponding to each theme. Additionally, we highlight priority areas necessitating further investigation.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.270
metaresearch head score (Gemma)0.274
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesMetaresearch
DomainCandidate signal: Methods · Consensus signal: none
Study designCandidate signal: Qualitative · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.730
Threshold uncertainty score0.900

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.2700.274
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0030.003
Bibliometrics0.0040.004
Science and technology studies0.0010.003
Scholarly communication0.0100.010
Open science0.0030.006
Research integrity0.0040.008
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.634
GPT teacher head0.629
Teacher spread0.005 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; the direct Gemma label and the distilled Codex classifier agree on what is shown here.

Study designQualitative
DomainMethods
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations18
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueEClinicalMedicineSame topicHealth Systems, Economic Evaluations, Quality of LifeFrench-language works237,207